Registration Decision RD2021-01, Trifludimoxazin, Vulcarus and Voraxor
This decision is consistent with the Proposed Registration Decision PRD2020-15, Trifludimoxazin, Vulcarus and Voraxor, which contains a detailed evaluation of the information submitted in support of this registration.
- Publisher - Current Organization Name: Health Canada
- Licence: Open Government Licence - Canada
Data and Resources
-
Registration Decision RD2021-01, Trifludimoxazin, Vulcarus and VoraxorHTMLEnglish publication HTML
-
Registration Decision RD2021-01, Trifludimoxazin, Vulcarus and VoraxorHTMLFrench publication HTML
Similar records